133 related articles for article (PubMed ID: 1780043)
1. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
Bousselmame R; Eustache M; Michael-Titus A; Costentin J
Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
[TBL] [Abstract][Full Text] [Related]
2. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan.
Khallouk-Bousselmame R; Costentin J
Eur Neuropsychopharmacol; 1994 Jun; 4(2):137-43. PubMed ID: 7919943
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
4. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
Malin DH; Lake JR; Hamilton RF; Skolnick MH
Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
[TBL] [Abstract][Full Text] [Related]
5. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz JC
Neuropharmacology; 1989 Feb; 28(2):117-22. PubMed ID: 2716968
[TBL] [Abstract][Full Text] [Related]
7. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
Lambert DM; Mergen F; Poupaert JH; Dumont P
Eur J Pharmacol; 1993 Oct; 243(2):129-34. PubMed ID: 8276061
[TBL] [Abstract][Full Text] [Related]
8. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
Nouel D; Dubuc I; Kitabgi P; Costentin J
Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
[TBL] [Abstract][Full Text] [Related]
9. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
Rivière PJ; Buéno L
Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of mu-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor.
Bousselmame R; Michael-Titus A; Costentin J
Eur J Pharmacol; 1991 Oct; 203(2):295-7. PubMed ID: 1666049
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor.
Knisely JS; Beardsley PM; Aceto MD; Balster RL; Harris LS
Drug Alcohol Depend; 1989 Apr; 23(2):143-51. PubMed ID: 2702924
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
[TBL] [Abstract][Full Text] [Related]
13. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
Adjroud O
J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
Michael-Titus A; Preterre P; Giros B; Costentin J
J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.
Lambert DM; Mergen F; Berens CF; Poupaert JH; Dumont P
Pharm Res; 1995 Feb; 12(2):187-91. PubMed ID: 7784331
[TBL] [Abstract][Full Text] [Related]
16. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
[TBL] [Abstract][Full Text] [Related]
17. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
[TBL] [Abstract][Full Text] [Related]
18. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
[TBL] [Abstract][Full Text] [Related]
19. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
Suh HH; Tseng LL
Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
